-
Inhaled Form of Teicoplanin for CF Patients Goal of Italfarmaco, Neupharma Partnernership
Italfarmaco and Neupharma plan to develop an inhaled formulation of the antibiotic teicoplanin to treat resistant, Gram-positive bacteria like MRSA. Read more about it.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.